Company Valuation: West Pharmaceutical Services, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 34,744 17,424 26,053 23,723 19,795 24,848 - -
Change - -49.85% 49.53% -8.95% -16.56% 25.53% - -
Enterprise Value (EV) 1 34,744 16,738 25,406 23,441 19,206 24,345 23,809 23,390
Change - -51.82% 51.78% -7.74% -18.07% 26.76% -2.2% -1.76%
P/E 54.1x 30.4x 44.7x 49x 40.5x 41.2x 35.8x 32x
PBR 14.9x 6.5x 8.98x 8.83x 5.95x 7.94x 6.93x 6.13x
PEG - -2.8x 23.04x -3.2x 27.09x 1.6x 2.4x 2.7x
Capitalization / Revenue 12.3x 6.04x 8.83x 8.2x 6.44x 7.36x 6.93x 6.45x
EV / Revenue 12.3x 5.8x 8.61x 8.1x 6.25x 7.21x 6.64x 6.07x
EV / EBITDA 39.3x 19x 30.7x 32.2x 24.2x 25.9x 22.9x 20.2x
EV / EBIT 45.6x 22x 36.8x 40.9x 30.9x 32.1x 28.1x 24.6x
EV / FCF 105x 38.1x 61.3x 84.8x 41x 56.5x 42x 32.3x
FCF Yield 0.95% 2.63% 1.63% 1.18% 2.44% 1.77% 2.38% 3.1%
Dividend per Share 2 0.69 0.74 0.78 0.82 0.85 0.9025 0.9729 1.121
Rate of return 0.15% 0.31% 0.22% 0.25% 0.31% 0.26% 0.28% 0.32%
EPS 2 8.67 7.73 7.88 6.69 6.79 8.575 9.865 11.04
Distribution rate 7.96% 9.57% 9.9% 12.3% 12.5% 10.5% 9.86% 10.2%
Net sales 1 2,832 2,887 2,950 2,893 3,074 3,375 3,587 3,854
EBITDA 1 884.7 882.6 827.9 728.2 793.8 940.4 1,041 1,159
EBIT 1 762.4 762 690.6 572.8 622.4 757.5 848.4 952.3
Net income 1 661.8 585.9 593.4 492.7 493.7 614.5 701.2 778
Net Debt 1 - -685.4 -647.1 -282 -588.5 -503.3 -1,039 -1,458
Reference price 2 469.01 235.35 352.12 327.56 275.14 353.08 353.08 353.08
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 70,376 - -
Announcement Date 2/17/22 2/16/23 2/15/24 2/13/25 2/12/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
33.46x4.49x17.25x2.2% 202B
21.15x3.63x12.76x3.19% 119B
17.42x0.2x12.74x0.75% 60.69B
30.35x7.55x19.27x1.31% 52.38B
37x3.53x12.12x2.04% 52.3B
37.01x6.52x20.46x-.--% 34.85B
44.97x1.28x11.71x0.17% 30.06B
41.17x7.21x25.89x0.26% 24.85B
19.84x3.06x11.16x1.45% 23.84B
Average 31.38x 4.16x 15.93x 1.26% 66.7B
Weighted average by Cap. 29.99x 4.08x 15.65x 1.82%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. WST Stock
  4. WST * Stock
  5. Valuation West Pharmaceutical Services, Inc.